ADGRE2 |
Q9UHX3
|
adhesion G protein-coupled receptor E2
|
G-protein coupled receptor
|
2.8E-28 |
0.581 |
0.615 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CD163 |
Q86VB7
|
CD163 molecule
|
Enzyme
|
8.3E-04 |
0.427 |
0.846 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
DUSP4 |
Q13115
|
dual specificity phosphatase 4
|
|
0.88 |
0.603 |
0.654 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
ESR1 |
P03372
|
estrogen receptor 1
|
Nuclear receptor
|
1.00 |
0.324 |
0.962 |
ESR2 |
Q92731
|
estrogen receptor 2
|
Nuclear receptor
|
4.5E-08 |
0.400 |
0.923 |
FGFR1 |
P11362
|
fibroblast growth factor receptor 1
|
Kinase
|
1.00 |
0.362 |
0.885 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
HPSE |
Q9Y251
|
heparanase
|
Enzyme
|
2.3E-14 |
0.425 |
0.808 |
IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
KLF6 |
Q99612
|
Kruppel like factor 6
|
Nucleic acid binding
|
0.98 |
0.501 |
0.846 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
MDM2 |
Q00987
|
MDM2 proto-oncogene
|
Nucleic acid binding
|
1.00 |
0.362 |
0.846 |
MET |
P08581
|
MET proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.97 |
0.380 |
0.846 |
MIB1 |
Q86YT6
|
mindbomb E3 ubiquitin protein ligase 1
|
Enzyme
|
3.4E-88 |
0.438 |
0.769 |
MKI67 |
P46013
|
marker of proliferation Ki-67
|
|
1.3E-28 |
0.431 |
0.808 |
MMP2 |
P08253
|
matrix metallopeptidase 2
|
Enzyme
|
0.84 |
0.333 |
0.923 |
MMP3 |
P08254
|
matrix metallopeptidase 3
|
Enzyme
|
5.7E-15 |
0.408 |
0.885 |
MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |